Thomas M Kündig Selected Research

Thomas M Kündig Research Topics

Disease

32	Hypersensitivity (Allergy) 01/2022 - 03/2002
13	Neoplasms (Cancer) 01/2022 - 06/2005
8	Inflammation (Inflammations) 01/2022 - 06/2007
7	Infections 01/2022 - 03/2002
6	Anaphylaxis (Anaphylactic Shock) 01/2020 - 12/2005
3	Pruritus (Itching) 10/2021 - 12/2011
3	Insect Bites and Stings (Insect Bite) 01/2020 - 10/2018
3	Eczema 01/2015 - 11/2009
3	Asthma (Bronchial Asthma) 06/2011 - 12/2006
2	Lymphoma (Lymphomas) 01/2022 - 07/2021
2	Bites and Stings (Sting) 01/2022 - 01/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 06/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2013
2	Rheumatoid Arthritis 01/2018 - 06/2007
2	Allergic Rhinitis 01/2015 - 08/2014
2	Contact Dermatitis (Eczema, Contact) 06/2010 - 03/2002
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Leukemia 01/2022
1	Eosinophilia 10/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2021
1	Peanut Hypersensitivity (Peanut Allergy) 01/2020
1	Chronic Disease (Chronic Diseases) 10/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Colitis 01/2018
1	Cowpox 10/2014
1	Food Hypersensitivity (Food Allergy) 01/2014
1	Disease Progression 03/2013
1	Atherosclerosis 03/2013
1	Mycosis Fungoides 02/2013
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2013

Drug/Important Bio-Agent (IBA)

22	AllergensIBA 10/2021 - 12/2005
15	VaccinesIBA 01/2022 - 07/2004
11	Immunoglobulin E (IgE)IBA 01/2022 - 11/2008
5	AntigensIBA 01/2022 - 10/2009
4	Immunoglobulin G (IgG)IBA 01/2022 - 12/2005
4	CytokinesIBA 10/2021 - 06/2007
3	AntibodiesIBA 01/2022 - 08/2010
3	Interleukin-5 (Interleukin 5)IBA 10/2021 - 10/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 04/2009
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
2	Bee Venoms (Bee Venom)IBA 01/2022 - 01/2013
2	Messenger RNA (mRNA)IBA 07/2021 - 01/2021
2	AluminumIBA 01/2020 - 03/2018
2	Neutralizing AntibodiesIBA 01/2020 - 03/2013
2	SaltsIBA 01/2020 - 03/2018
2	InterleukinsIBA 01/2020 - 03/2013
2	Clemastine (Clemastine Fumarate)FDA LinkGeneric 02/2013 - 12/2011
2	Histamine Antagonists (Antihistamines)IBA 02/2013 - 12/2011
2	Arthropod VenomsIBA 01/2013 - 12/2006
2	CPG-oligonucleotideIBA 11/2012 - 06/2005
2	OligonucleotidesIBA 11/2012 - 03/2002
2	Peptides (Polypeptides)IBA 06/2007 - 03/2002
1	Pentostatin (Nipent)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Toll-Like Receptor 3IBA 01/2022
1	Interferon Type IIBA 01/2022
1	Adenosine DeaminaseIBA 01/2022
1	Interleukin-12 (IL 12)IBA 10/2021
1	Interleukin-23 Subunit p19IBA 10/2021
1	Imiquimod (Aldara)FDA LinkGeneric 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2021
1	Therapeutic UsesIBA 07/2021
1	BNT162 VaccineIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Histocompatibility Antigens Class IIBA 01/2020
1	monophosphoryl lipid AIBA 01/2020
1	hypoxanthine arabinoside (ara-H)IBA 01/2020
1	AutoantibodiesIBA 10/2018
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 03/2018
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2018
1	InflammasomesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	aluminum sulfate (alum)IBA 01/2018
1	Interleukin-2 (IL2)IBA 07/2015
1	Photosensitizing Agents (Photosensitizers)IBA 07/2015
1	Apolipoproteins E (ApoE)IBA 03/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2013
1	Transcription Factors (Transcription Factor)IBA 02/2013
1	desloratadine (Aerius)FDA LinkGeneric 02/2013
1	Complement System Proteins (Complement)IBA 02/2013
1	STAT Transcription FactorsIBA 02/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2013
1	Wasp Venoms (Venom, Wasp)IBA 01/2013
1	Macrophage Colony-Stimulating FactorIBA 12/2012
1	MART-1 AntigenIBA 11/2012
1	LigandsIBA 11/2012

Therapy/Procedure

19	Immunotherapy 10/2021 - 12/2006
6	Therapeutics 01/2022 - 06/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 02/2013
2	Injections 05/2012 - 11/2009
1	Microspheres (Microsphere) 10/2021
1	Duration of Therapy 02/2016